Navigation Links
WeissComm Launches Invigorate Communications to Help Companies Build Successful Health-Based Brands
Date:10/14/2008

Tali Kaplan Joins as Associate Director

SAN FRANCISCO, and SUMMIT, N.J., Oct. 14 /PRNewswire-FirstCall/ -- WeissComm Group today announced that it has launched Invigorate Communications, a full-service public relations agency focused on serving the diverse communications needs of leading biopharmaceutical, device, healthcare service and consumer companies, particularly those interested in building health-based brands. Invigorate currently provides corporate, product, investor and advocacy communications support to several biopharmaceutical companies.

Invigorate leverages the success of WeissComm Partners, the largest, independent public relations firm focused exclusively on healthcare, which recently was named "Healthcare Agency of Year" by the Holmes Report.

"Clients have always come to WeissComm for senior level counselors who understand their business better than anyone," said Jim Weiss, CEO and chairman of WeissComm Group. "Now Invigorate also provides a team of professionals who are highly knowledgeable and passionate about healthcare and offer a unique combination of intelligence, strategy and hands-on service to support our clients' core business goals."

Led by Managing Director Tom Jones, Invigorate Communications is headquartered in Summit, N.J. with offices in San Francisco and Los Angeles. Jones was formerly an executive director of communications at Novartis Pharmaceuticals Corporation and an integral leader of Ketchum Public Relations' healthcare practice. He has a successful track record of developing and executing award-winning public relations and corporate communications initiatives focused on reaching consumers and encouraging interactive and productive dialogue between patients, caregivers and physicians.

WeissComm also announced that Tali Kaplan, a 20-year veteran of the healthcare industry, has been named associate director of Invigorate. She joins from CarryOn Communications, where she was responsible for leading that agency's health and nutrition practice and providing communications support for some of the most familiar and popular consumer brands. Previously, Ms. Kaplan was vice president of global communications at Baxter BioScience after serving for several years in Baxter's regulatory affairs group. A licensed R.N. with clinical experience in neurology/neurosurgery and hospice, she started her biopharmaceutical career in the regulatory affairs department at Genentech where she focused on quality assurance and compliance for the company's numerous clinical trials.

Invigorate Communications provides a range of services including consumer marketing, healthcare communications, issues and crisis management, corporate reputation, media relations, interactive marketing, corporate and product branding, investor relations, public affairs, advocacy relations and internal communications.

"Because consumers have become increasingly integral to the healthcare decision-making process, Invigorate taps into the 'consumerization' of healthcare," said Diane Weiser, President and COO of WeissComm Group. "We rely on cutting-edge research and our years of experience to understand what makes our clients' target audiences tick - and we utilize integrated, highly targeted communications via new and traditional media vehicles that capture their imaginations, stimulate the right conversations and create a call to action."

For more information, please visit http://www.invigoratepr.com.


'/>"/>
SOURCE Invigorate Communications
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cephalon Launches National Consumer Awareness Initiative on Appropriate Use of Prescription Opioid Medications
2. MRI Expands Energy Role: Launches Center for Integrated Algal Research and Creates Director of Energy Programs Position
3. Finesse Solutions Launches TruBio 3.4 Bioreactor Control Software
4. Finesse Solutions Launches Improved E-Store for Sensors and Transmitters
5. Allied Healthcare Launches First of Line of Ventilators Designed to Meet Demands of Mass Casualty Incidents
6. GenVault Corporation Launches GenTegra(TM) DNA
7. Complete Genomics Launches, Becomes Worlds First Large-Scale Human Genome Sequencing Company
8. Simbionix Launches Innovative Patient-Specific Simulation
9. CISBIO Bioassays Launches Chromoa(TM) Chromogranin A ELISA Kit
10. Cyntellect Launches CellXpress(TM) System to Boost Productivity of Biopharmaceutical Process Development
11. Histogen Launches BioNuesis, the Only All-Human Stem Cell Culturing Kit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... ... January 18, 2017 , ... Executive search firm ... its continued commitment to the advancement of the clinical trials segment. Hosted in ... to clinical trial planning and management. , As executive talent specialists in ...
(Date:1/18/2017)... NY (PRWEB) , ... January 18, 2017 , ... Researchers from a new study ... do not fall low enough after prostate cancer treatment, this indicates there is still remaining ... risk of mortality. , “ The PSA test has always been an indicator of whether ...
(Date:1/18/2017)... , Jan. 18, 2017 Shareholder rights law ... into whether the board members of CoLucid Pharmaceuticals, Inc. ... in connection with the proposed sale of the Company ... company that develops small molecules for the acute treatment ... announced it had signed a definitive merger agreement with ...
(Date:1/17/2017)... ... January 17, 2017 , ... LGC ... to its VALIDATE® SP2 calibration verification / linearity test kit. VALIDATE® SP2 evaluates ... Each VALIDATE® SP2 kit is prepared using the CLSI recommended “equal delta” method ...
Breaking Biology Technology:
(Date:12/16/2016)... 2016 Research and Markets has announced the ... Forecast to 2021" report to their offering. ... The biometric vehicle access system ... CAGR of 14.06% from 2016 to 2021. The market is estimated ... reach 854.8 Million by 2021. The growth of the biometric vehicle ...
(Date:12/15/2016)... Calif. , Dec. 15, 2016   WaferGen ... publicly held genomics technology company, announced today that on ... Listing Qualifications Department of The Nasdaq Stock Market LLC ... closing bid price of WaferGen,s common stock had been ... Accordingly, WaferGen has regained compliance with Listing Rule 5550(a)(2) ...
(Date:12/15/2016)... , Dec. 15, 2016  There is much more ... or starting the engine. Continental will demonstrate the intelligence ... Las Vegas . Through the combination of the ... Entry) and biometric elements, the international technology company is ... personalization and authentication. "The integration of biometric ...
Breaking Biology News(10 mins):